Ophthalmology · Chula Vista, CA
NPI
1346687233
Since 2013
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
342 F St
Chula Vista, CA, 91910
Phone (619) 422-1471
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,173 services
Medicare patients, 2024
212
Average age 74
Drug cost, 2024
$2.0M
6,843 prescriptions
Company payments, 2025
$1,102
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Zabaneh was code 99213 (office e&m - established), 218 times for 119 patients. In total Alexander Zabaneh billed 1,173 services in 26 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 218 | 119 | $72.19 | $16K |
| 92083 Vision, Hearing, and Speech Services | Office | 145 | 105 | $52.40 | $7,598 |
| 92014 Ophthalmological E&M | Office | 139 | 119 | $101.26 | $14K |
| 99214 Office E&M - Established | Office | 121 | 85 | $101.49 | $12K |
| 92133 Computerized Ophthalmic Imaging | Office | 106 | 93 | $28.05 | $2,973 |
| 92134 Computerized Ophthalmic Imaging | Office | 106 | 95 | $33.09 | $3,507 |
| 92250 Angiography | Office | 106 | 98 | $29.50 | $3,127 |
| 76514 Ultrasound - Nonspecific | Office | 81 | 77 | $8.39 | $680 |
| 92136 Ultrasound - Nonspecific | Office | 23 | 19 | $35.74 | $822 |
| 92020 Ophthalmological E&M | Office | 22 | 21 | $21.65 | $476 |
| 92004 Ophthalmological E&M | Office | 20 | 20 | $104.01 | $2,080 |
| 92012 Ophthalmological E&M | Office | 18 | 15 | $63.63 | $1,145 |
| 66984 Cataract Surgery | Facility | 16 | 15 | $436.36 | $6,982 |
By year: 2022 $77K for 1,167 services; 2023 $90K for 1,235 services; 2024 $83K for 1,173 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Zabaneh prescribed most often to Medicare patients was Simbrinza (Brinzolamide/Brimonidine Tart), with 965 prescriptions and refills. In total Alexander Zabaneh wrote 6,843 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Simbrinza Brinzolamide/Brimonidine Tart | 965 | 1,366 | 212 | $258K |
| Timolol Maleate Generic | 646 | 1,243 | 170 | $72K |
| Lumigan Bimatoprost | 563 | 921 | 169 | $232K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 560 | 788 | 145 | $276K |
| Vyzulta Latanoprostene Bunod | 534 | 836 | 151 | $227K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 451 | 919 | 133 | $9,906 |
| Latanoprost Generic | 412 | 727 | 130 | $5,365 |
| Rhopressa Netarsudil Mesylate | 404 | 556 | 114 | $168K |
| Xiidra Lifitegrast | 381 | 508 | 154 | $339K |
| Prednisolone Acetate Generic | 280 | 351 | 188 | $13K |
| Dorzolamide Hcl Generic | 143 | 276 | 47 | $2,652 |
| Moxifloxacin Moxifloxacin Hcl | 141 | 141 | 104 | $4,262 |
| Brimonidine Tartrate Generic | 134 | 213 | 40 | $9,874 |
| Ketorolac Tromethamine Generic | 129 | 144 | 97 | $1,829 |
| Alphagan P Brimonidine Tartrate | 105 | 179 | 35 | $48K |
Brand drugs: 4,828 claims; generic drugs: 2,015 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Zabaneh $1,102 ($1,102 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sight Sciences, Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Sight Sciences, Inc. SGHT | 2 | $297 |
| Abbvie Inc. ABBV | 8 | $187 |
| Alcon Vision LLC ALC | 7 | $167 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $137 |
| Harrow Eye, LLC | 3 | $97.14 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $67.03 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $45.29 |
| Astellas Pharma US Inc 4503.T | 1 | $34.06 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $32.85 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.